Latest news and updates on the project.
Eight Patients are now Enrolled in the ImmuoSABR Clinical Trial
Our trial is steadily progressing and we now have eight patients in three centres enrolled in the ImmunoSABR trial .
First Patients Enrolled in ImmuoSABR Clinical Trial
Great news the first patients have been enrolled in the ImmunoSABRclinical Trial at NKI and AZM
METC approval received for the centres in Maastricht, Amsterdam and Nijmegen
Annual ImmunoSABR Meeting 2019
Partners Meeting held in Amsterdam reporting on the progress of the project.
New ImmunoSABR Website Launched
A new website has been designed to provide an overview of the ImmunoSABR project, its progress and information to the general public, patients and potential patients
Presentation – Brussels & Roma
Professor Philippe Lambin – Immunocytokines and Radiation at the Institut Bordet, Brussels. Unconventional immunotherapy and Radiation given in Roma at the yearly national course of radiation Oncology
Presentation – Paris
Professor Philippe Lambin given in Paris at the Immunorad meeting immunocytokines and radiation
Presentation – New York
Professor Philippe Lambin given in New York MSKCC on Immunocytokines and radiation
Presentation – Liverpool UK
Professor Philippe Lambin on Immunocytokines and Radiation given in Liverpool UK at UK Radiological Congress and Radiation and Oncology Congress (UKRCO)
Amendment EU, Periodic report, (Ready for) Submission
Protocol final, ICF and patient info final, Other documents for submission final, EU amendment Part A and B final, EU Technical Report part B final, CTA final and signed, Finalizing deliverables
New data with three tumour models form the M-lab of precision medicine showing that immunocytokines, used in ImmunoSABR, worked better than checkpoint inhibitors with radiation.
Presentation by Professor Philippe Lambin in Antwerpen on ImmunoSABR led to them becoming a participant
Presentation – Barcelona
Presentation by Professor Philippe Lambin (The M-Lab of Precision medicine) given at the ESTRO meeting in Barcelona on novel immunotherapy radiotherapy strategies Presentation by Damienne Marcus (The M-Lab of Precision medicine) given at the ESTRO meeting in Barcelona in on immunocytokines and radiation
Presentation – Utrecht
Presentation by Professor Philippe Lambin given at the NVRO-NVRB meeting in Utrecht in on immunocytokines and radiation
Tender (Negometrix), Submissions, Safety reporting, Risk analysis, Local monitors (visits), Training partners, Trial master file
Kick Off Meeting – Presentation
First presentation was given by Professor Philippe Lambin , Brussels Kick off meeting introducing ImmunoSABR for a broad audience.
H2020 grant – We received an H2020 grant from the European Union that helps us to cover the financial part for this study. We are working with a number of hospitals and centres throughout the European Union and aim to encompass patients within the whole of the EU
STAY INFORMED ?
If you want to stay informed about ImmunoSABR project, please subscribe to our newsletter.
The D-Lab / Precision Medicine
P.O. Box 616,
6200 MD Maastricht, The Netherlands
This project has received funding from the European Union’s. Horizon 2020 research and innovation programme under grant agreement No 733008